Dynavax Other Liab from 2010 to 2024

DVAX Stock  USD 12.42  0.06  0.49%   
Dynavax Technologies Other Liabilities yearly trend continues to be fairly stable with very little volatility. Other Liabilities will likely drop to about 328.3 K in 2024. During the period from 2010 to 2024, Dynavax Technologies Other Liabilities regression line of annual values had r-squared of  0.28 and arithmetic mean of  3,424,928. View All Fundamentals
 
Other Liabilities  
First Reported
2004-03-31
Previous Quarter
60.7 M
Current Value
60.7 M
Quarterly Volatility
22.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dynavax Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dynavax Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.7 M, Interest Expense of 4 M or Other Operating Expenses of 282.8 M, as well as many indicators such as Price To Sales Ratio of 7.36, Dividend Yield of 0.0 or PTB Ratio of 4.48. Dynavax financial statements analysis is a perfect complement when working with Dynavax Technologies Valuation or Volatility modules.
  
Check out the analysis of Dynavax Technologies Correlation against competitors.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Latest Dynavax Technologies' Other Liab Growth Pattern

Below is the plot of the Other Liab of Dynavax Technologies over the last few years. It is Dynavax Technologies' Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dynavax Technologies' overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Slightly volatile
   Other Liab   
       Timeline  

Dynavax Other Liab Regression Statistics

Arithmetic Mean3,424,928
Geometric Mean1,818,349
Coefficient Of Variation94.49
Mean Deviation2,922,991
Median2,136,000
Standard Deviation3,236,146
Sample Variance10.5T
Range8.6M
R-Value(0.53)
Mean Square Error8.1T
R-Squared0.28
Significance0.04
Slope(381,901)
Total Sum of Squares146.6T

Dynavax Other Liab History

2024328.3 K
2023345.6 K
2022384 K
20215.7 M
20202.6 M
20191.3 M
20188.9 M

About Dynavax Technologies Financial Statements

Dynavax Technologies investors use historical fundamental indicators, such as Dynavax Technologies' Other Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dynavax Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Liabilities345.6 K328.3 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.